x

About This IV

Relax & Anti-Stress+ is a precision neuro-endocrine IV formula targeting the complete biochemical cascade of the stress response — from the hypothalamic-pituitary-adrenal (HPA) axis activation through cortisol biosynthesis, glucocorticoid receptor signalling, GABA/glutamate balance, sympathetic nervous system hyperactivity, and the downstream depletion of neurotransmitter precursors and micronutrients that chronic stress produces. The formula is designed not as a sedative or anxiolytic (which suppress neurological function nonspecifically) but as a restorative intervention that replenishes every biochemical resource depleted by chronic stress while simultaneously modulating the specific receptors and enzyme systems that maintain the stress response in a chronically activated state. The stress response begins in the hypothalamus with CRH (corticotropin-releasing hormone) release, triggering ACTH from the pituitary, which drives cortisol synthesis in the adrenal cortex. Cortisol — the primary glucocorticoid — is essential for acute stress management (mobilising glucose, suppressing immune activation, enhancing alertness) but chronically elevated cortisol produces a cascade of neurological, metabolic, and immunological damage: hippocampal neuronal atrophy (glucocorticoid receptor activation in CA3 hippocampal neurons drives dendritic retraction and impairs LTP/memory), prefrontal cortical thinning (chronic cortisol reduces BDNF expression and dendritic complexity in PFC layer II/III pyramidal neurons that govern executive function and stress regulation), adrenal fatigue (sustained ACTH drive depletes adrenal cortisol synthetic capacity and depletes the B5-dependent CoA pool required for steroidogenesis), and depletion of serotonin, GABA, magnesium, zinc, and B-vitamins — the very resources required to terminate the stress response. Relax & Anti-Stress+ replenishes all of these depleted resources simultaneously while delivering compounds that directly modulate HPA axis activity, GABA receptor function, and cortisol clearance. Magnesium (1000mg) is the single most important anti-stress mineral and is provided at the maximum therapeutic IV dose. Magnesium's stress-modulating mechanisms span four independent pathways: (1) NMDA receptor antagonism — Mg²⁺ is the physiological voltage-dependent blocker of NMDA receptors. Chronic stress increases glutamatergic tone in the amygdala and increases NMDA receptor expression, promoting a hyperexcitable state characterised by anxiety, hypervigilance, and exaggerated stress responses. Magnesium at 1000mg IV increases synaptic Mg²⁺ concentrations to re-establish appropriate NMDA channel blocking, reducing the excitatory-inhibitory imbalance in stress circuits. (2) GABA-A positive allosteric modulation — Mg²⁺ at pharmacological concentrations acts as a positive allosteric modulator of GABA-A receptors, enhancing chloride channel conductance and increasing the inhibitory tone that counteracts sympathetic hyperactivation. (3) HPA axis suppression — magnesium directly inhibits CRH release from the hypothalamic paraventricular nucleus (PVN) and reduces pituitary sensitivity to CRH by suppressing adenylyl cyclase activity (Mg²⁺ inhibits Gs-coupled receptor signalling). Magnesium-deficient states are associated with higher basal cortisol and greater cortisol reactivity to psychological stressors. (4) Adrenal cortisol synthesis modulation — magnesium is required for the mitochondrial StAR (steroidogenic acute regulatory protein) transport that moves cholesterol into the inner mitochondrial membrane for cortisol synthesis; paradoxically, pharmacological magnesium loads suppress StAR expression, reducing adrenal cortisol output during infusion. Taurine (250mg) provides complementary GABAergic modulation through a separate mechanism: taurine is an endogenous agonist at GABA-A receptors (specifically the δ-subunit-containing extrasynaptic GABA-A receptors that mediate tonic inhibition — the sustained background inhibitory tone that determines the set-point for neuronal excitability throughout the brain). Extrasynaptic GABA-A receptors are particularly concentrated in the hippocampus, cerebellum, and thalamus — the circuits governing stress reactivity and emotional regulation. Taurine at 250mg IV achieves concentrations sufficient to activate these extrasynaptic receptors, producing a tonic inhibitory state that reduces the background excitability of the stress circuitry without the phasic (on/off) sedative effects of benzodiazepines (which primarily target synaptic GABA-A receptors). Taurine also acts as a glycine receptor agonist in the spinal cord and brainstem, reducing sympathetic preganglionic neuron firing and lowering the tonic sympathetic tone that maintains the fight-or-flight state. Additionally, taurine conjugates with cortisol metabolites in the liver to enhance glucocorticoid clearance — taurine-cortisol conjugates are more rapidly excreted in bile than unconjugated cortisol metabolites, reducing the circulating cortisol half-life and accelerating HPA axis recovery. Inositol (200mg) targets the serotonin 5-HT2A and 5-HT2C receptor second messenger system — the intracellular signalling pathway through which serotonin exerts its anxiolytic effect. When 5-HT2A/2C receptors are activated by serotonin, they couple to Gq protein, activating PLC (phospholipase C) to cleave PI(4,5)P2 into IP3 (inositol-1,4,5-trisphosphate) and DAG (diacylglycerol). IP3 triggers Ca²⁺ release from the endoplasmic reticulum, activating calcineurin and CaMKII signalling cascades that produce the anxiolytic, mood-stabilising effects of serotonin in the prefrontal cortex and amygdala. Chronic stress depletes the PI(4,5)P2 pool by continuous PLC activation, impairing 5-HT2 receptor signal transduction. Inositol (200mg IV) directly replenishes the myo-inositol pool used to resynthesize PI(4,5)P2 — restoring 5-HT2 receptor signalling efficacy without altering serotonin levels or receptor expression. This mechanism explains the clinical efficacy of inositol in panic disorder and OCD (both conditions of impaired 5-HT2 signalling) and why IV inositol produces a notably faster anxiolytic effect than oral supplementation (bypassing the rate-limiting intestinal absorption step). N-Acetylcysteine (500mg) provides cortisol-buffering neuroprotection via three mechanisms. First, cortisol activates NADPH oxidase in hippocampal neurons, generating superoxide that depletes neuronal GSH — NAC restores neuronal GSH and activates Nrf2, reversing cortisol-mediated oxidative damage. Second, NAC modulates the cystine/glutamate antiporter (system Xc⁻), reducing extracellular glutamate overflow in the amygdala that drives anxiety and hypervigilance — system Xc⁻ exports glutamate while importing cystine; NAC at high concentrations saturates cystine import, competitively reducing glutamate export and thereby lowering perisynaptic glutamate levels in the amygdala. Third, NAC inhibits NF-κB activation in microglia, reducing neuroinflammatory cytokine production (IL-6, TNF-α, IL-1β) that is elevated by chronic stress and that directly activates the HPA axis via interleukin-driven CRH release. Trimethylglycine (1000mg) — the highest dose of any component other than Vitamin C and Magnesium — serves multiple anti-stress functions. As the primary methyl donor via BHMT (betaine:homocysteine methyltransferase), TMG regenerates methionine from homocysteine, maintaining SAM (S-adenosylmethionine) pools. SAM is the methyl donor for COMT (catechol-O-methyltransferase) — the enzyme that inactivates catecholamines (dopamine, norepinephrine, epinephrine) in the synapse. Chronic stress elevates catecholamine levels and COMT demand, depleting SAM and impairing catecholamine inactivation — contributing to the persistent sympathetic overdrive of chronic stress. TMG at 1000mg replenishes SAM and maintains COMT activity, facilitating appropriate catecholamine clearance and sympathetic de-activation. TMG also acts as an osmolyte in neurons and glial cells, counteracting the cell volume changes caused by stress-induced changes in extracellular osmolarity. Vitamin C (5000mg) targets the adrenal cortex specifically — the adrenal glands have the highest Vitamin C concentration of any tissue in the body (10–50× plasma levels), maintained by the sodium-dependent Vitamin C transporter SVCT2. Vitamin C is consumed during cortisol synthesis (as cofactor for dopamine-β-hydroxylase in the adjacent catecholamine synthesis pathway, which shares adrenal chromaffin cells with cortisol synthesis) and during the hydroxylation reactions of steroidogenesis. Chronic stress depletes adrenal Vitamin C stores, impairing both the regulation of cortisol synthesis and the synthesis of catecholamines. At 5000mg IV, Vitamin C rapidly replenishes adrenal stores via SVCT2-mediated active uptake, restoring adrenal function and reducing the excessive cortisol output of chronically stimulated adrenal glands. Vitamin C also inhibits cortisol biosynthesis post-hoc by reducing the activity of 11β-hydroxylase (CYP11B1) — the final enzyme in cortisol synthesis — at pharmacological concentrations. Dexpanthenol B5 (500mg) addresses adrenal fatigue directly: Coenzyme A (synthesised from pantothenate/B5) is required for all steroidogenesis — cholesterol must be esterified with CoA (as cholesterol ester) for transport in lipoproteins, and each step of the cortisol synthesis pathway (cholesterol → pregnenolone → progesterone → 17-OH-progesterone → 11-deoxycortisol → cortisol) involves CoA-dependent reactions or requires CoA-synthesised cofactors. In B5-deficient states (common after prolonged stress that depletes adrenal CoA pools), adrenal cells cannot maintain steroidogenic capacity — the dysregulation manifests as both blunted cortisol response (adrenal exhaustion phase) and impaired adrenaline synthesis. B5 (500mg IV) restores adrenal CoA pools, normalising steroidogenic capacity and allowing appropriate (rather than excessive) cortisol production. The complete B-vitamin profile (B1 250mg, B2 5mg, B6 100mg, B12 1.5mg, B9 1mg) supports the mitochondrial energy metabolism of adrenal and neuronal cells under the high metabolic demand of the stress state, and B6 specifically is the obligate cofactor for the conversion of glutamate to GABA (via glutamate decarboxylase, GAD65/67) — the most important inhibitory neurotransmitter synthesis step for terminating anxious hyperarousal. B6 deficiency impairs GAD activity and reduces brain GABA synthesis capacity, maintaining an excitatory-inhibitory imbalance that perpetuates the stress state. Zinc (15mg) is required for glucocorticoid receptor (GR) function — the zinc finger DNA-binding domain of GR (a nuclear receptor) requires two Zn²⁺ ions for its structural integrity and DNA binding capacity. GR activation by cortisol normally drives negative feedback on CRH/ACTH production, terminating the HPA axis response. Zinc deficiency impairs GR DNA binding, blunting the cortisol negative feedback loop and causing runaway HPA axis activation — a well-documented mechanism in chronic stress-induced zinc depletion. At 15mg IV, Zinc restores GR function and supports cortisol negative feedback, allowing the HPA axis to respond normally to the elevated cortisol levels generated during stress. Selenium (0.05mg) activates selenoprotein P and thioredoxin reductase (TrxR) in adrenal and neuronal mitochondria — TrxR specifically reduces oxidised thioredoxin, regenerating the thioredoxin antioxidant cycle that protects adrenal steroidogenic enzymes (CYP11A1, CYP11B1) from oxidative inactivation during high cortisol synthesis periods. L-Glutamine (250mg) supports gut barrier integrity (preventing stress-induced gut permeability that generates LPS-driven systemic inflammation, a major activator of the HPA axis) and provides glutamate for GABA synthesis via GAD in inhibitory interneurons throughout the limbic system and prefrontal cortex — the regions most critical for HPA axis termination and emotional regulation.